Font Size: a A A

Controlled release formulation of 10-hydroxy-camptothecin using hydrophilic matrix system

Posted on:2009-10-01Degree:M.SType:Thesis
University:Long Island University, The Brooklyn CenterCandidate:Osei-Owusu, Luke KwabenaFull Text:PDF
GTID:2444390005455063Subject:Chemistry
Abstract/Summary:
The main objective of these studies was to formulate a controlled-released matrix system using Sodium CarboxymethylcelIulose as a hydrophilic polymeric carrier widely used in various pharmaceutical industries, to improve the performance of the matrix tablet containing the drug 10-hydroxycamptothecin (10HC). Efforts in formulating the drug are directed toward maintaining the lactone form of the drug for its potent antitumor activity which is known to be lost upon hydrolysis of the α-hydroxy-lactone ring of the drug.;In an effort to better understand the factors affecting the stability of the lactone form of 10HC and attain optimum formulation conditions, physicochemical characterization of the drug was conducted and several of the physical properties such as pKa, solubility and pH-depedent stability, were determined. The pKa determined was found to be 1.4.;The formulated solid dosage matrices were prepared by physical method in three forms that is, direct compression, wet granulation and lipid matrix formulation. Weight variance, hardness and disintegration tests were performed on the formulated matrices. Of all the matrices, the pH 1.2 granulation formulated matrix had the highest hardness of about 24 Lb and longest disintegration time >120 minutes.;In vitro studies were performed on the various matrices and their dissolution profiles compared based on the release rate and mechanisms. The pH 1.2 granulation matrix (F-5) and lipid formulation matrices (F-8, F-9 and F-10) release the drug with an almost zero-order release profile, while the rest of the formulated matrices yielded either Fickian or Anomalous drug release profile.;Data analysis indicated that the direct compression and the solvent evaporation method failed to prolong the release of the drug, that is, about 100% of the drug was released within 80 minutes in pH 1.2 dissolution media and 250 minutes in pH 6.8 dissolution media.;Analysis was also performed to predict the time for 80% release (t 80) of the drug as a function of the type of the formulation. More specifically, the drug released from the granulated formulation in pH 1.2 and pH 6.8 media were 50% and 80%, respectively, after 25 hours while about 95% of drug is released from the direct compression matrix system in about 4 hours in pH 6.8 dissolution media.;These results suggest that the most suitable formulation for the sustained release of 10-hydroxy-Camptothecin is the tablet matrix prepared with the method of granulation at pH 1.2 which gave an almost zero-order release profile.
Keywords/Search Tags:Release, Matrix, Formulation, Drug, Granulation
Related items
Development of an extended release naproxen sodium matrix tablet and evaluation of the effects of various fillers and additives on drug release kinetics
Effect And Evaluation Of Plasticizers On Drug Release In Glyceride And Acrylate Resin Matrix Tablets
Development, characterization and in-vivo evaluation of a zero-order release dosage form of a highly water soluble drug, niacin
Preperation And In Vitro Drug Releasing Study Of The Gastrodin Matrix Sustaind-release Tablets
Physicochemical charaterization of the anticancer drug camptothecin in acidic environment and design of oral sustained release formulation using hydrophilic polymer NA-CMC
Novel formulation: Development of oral microparticulate non-viral DNA vaccine delivery system against infectious hematopoietic necrosis virus (IHNV) in rainbow trout, statistical design in matrix tablets formulation
Modeling Study Of The Sustained-release And Controlled-release Formulation Based On The Quadratic Inference Functions
Development and characterization of poly (D, L-lactide-co-glycolide) based sustained release formulation of ganciclovir in treatment of cytomegalovirus retinitis
(1) Development and in vivo testing of a gastric retention device (GRD) in dogs, (2) Product formulations and in vitro-in vivo evaluation of, (a) immediate release formulation of itraconazole, (b) controlled-release formulation of ketoprofen in adult
10 Development and characterization of an extended release formulation of cyclobenzaprine hydrochloride using lipophilic and hydrophilic matrix components by fusion method